{
    "SPADE_UN_11347": {
        "Clinical Information": [
            {
                "Medical use": "Airway inflammation, chronic respiratory infection and cystic fibrosis, cnacer",
                "Company": "University of Miyazaki Third Department of Internal Medicine (Japan) and Papworth Hospital (UK).",
                "Stage of Development": "Phase II (Completed)",
                "Comments": "Peptide hormone that suppresses neutrophildominant inflammation in airways of patients with chronic respiratory infection.",
                "Clinical Trials": [
                    "NCT00681486",
                    "NCT01779024"
                ]
            }
        ],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11347",
            "Peptide Name": "Ghrelin",
            "Sequence": "GSSFLSPEHQRVQQRKESKKPPAKLQPR",
            "Source": "Endogenous host-defence peptide,Synthetic construct",
            "Target Organism": "No MICs found on DRAMP database",
            "Reference": [
                "Not available"
            ],
            "Biological Activity": [
                "Unknown"
            ],
            "Frequent Amino Acids": "KPQ",
            "Absent Amino Acids": "CDIMNOTUWY",
            "Basic Residues": 8,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 9,
            "Polar Residues": 18,
            "Positive Residues": 8,
            "Negative Residues": 2,
            "Mass": 3244.66,
            "PI": 11.07,
            "Net Charge": 6,
            "Hydrophobicity": -1.68,
            "Similar Sequences": []
        }
    }
}